Inventor · disambiguated record
Ho-Sik Oh
Also filed as: OH HO-SIK
9 granted patents·1 pending application·46 citations·filing 2015–2021
85Inventor score
Top patents by PatentIndex Score
10 records- 0196US10174122B2Anti-human 4-1BB antibodies and uses thereofEUTILEX CO LTD·Filed 2018·Granted Jan 8, 2019·23 cites·15 claims
- 0295US9862775B2Monoclonal antibody which specifically recognizes B cell lymphoma and use thereofEUTILEX CO LTD·Filed 2015·Granted Jan 9, 2018·15 cites·9 claims
- 0390US10233254B2Monoclonal antibody which specifically recognizes B cell lymphoma and use thereofEUTILEX CO LTD·Filed 2017·Granted Mar 19, 2019·4 cites·18 claims
- 0484US10919972B2Anti-human 4-1BB antibodies and uses thereofEUTILEX CO LTD·Filed 2018·Granted Feb 16, 2021·1 cites·2 claims
- 0583US10774151B2Anti-human 4-1BB antibodies and uses thereofEUTILEX CO LTD·Filed 2020·Granted Sep 15, 2020·1 cites·5 claims
- 0680US10801011B2Methods for isolating and proliferating autologous cancer antigen-specific CD8+ T cellsEUTILEX CO LTD·Filed 2017·Granted Oct 13, 2020·1 cites·8 claims
- 0779US10570371B2Methods for isolating and proliferating autologous cancer antigen-specific CD8+T cellsEUTILEX CO LTD·Filed 2018·Granted Feb 25, 2020·1 cites·15 claims
- 0873US11859004B2Anti-human 4-1BB antibodies and uses thereofEUTILEX CO LTD·Filed 2021·Granted Jan 2, 2024·0 cites·8 claims
- 0969US11396555B2Monoclonal antibody which specifically recognizes B cell lymphoma and use thereofEUTILEX CO LTD·Filed 2019·Granted Jul 26, 2022·0 cites·11 claims
- 1052US2015259646A1Methods for Isolating and Proliferating Autologous Cancer AntiGen-Specific CD8+ T CellsNAT CANCER CT·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Ho-Sik Oh files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →